Intravesical oxybutynin for treating incontinence resulting from an overactive detrusor.
about
Implantable Devices for Sustained, Intravesical Drug DeliveryRole of fesoterodine in the treatment of overactive bladder.Influence of urothelial or suburothelial cholinergic receptors on bladder reflexes in chronic spinal cord injured cats.Antimuscarinic drugs for the treatment of female urinary incontinence.
P2860
Intravesical oxybutynin for treating incontinence resulting from an overactive detrusor.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Intravesical oxybutynin for treating incontinence resulting from an overactive detrusor.
@ast
Intravesical oxybutynin for treating incontinence resulting from an overactive detrusor.
@en
Intravesical oxybutynin for treating incontinence resulting from an overactive detrusor.
@nl
type
label
Intravesical oxybutynin for treating incontinence resulting from an overactive detrusor.
@ast
Intravesical oxybutynin for treating incontinence resulting from an overactive detrusor.
@en
Intravesical oxybutynin for treating incontinence resulting from an overactive detrusor.
@nl
prefLabel
Intravesical oxybutynin for treating incontinence resulting from an overactive detrusor.
@ast
Intravesical oxybutynin for treating incontinence resulting from an overactive detrusor.
@en
Intravesical oxybutynin for treating incontinence resulting from an overactive detrusor.
@nl
P2860
P1433
P1476
Intravesical oxybutynin for treating incontinence resulting from an overactive detrusor.
@en
P2093
P2860
P304
P356
10.1046/J.1464-410X.2001.02227.X
P577
2001-06-01T00:00:00Z